drugset / Trial / NCT01290133
Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)
RandomizedParallel-groupSingle-blindBasic science
Summary
The purpose of this study is to describe the safety and tolerability and pharmacokinetics of a single intravenous administration of the new, Sulfobutyl Ether-7-Beta-Cyclodextrin (Captisol™) based, formulation in Healthy Adult Subjects.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vestipitant | Small molecule | — | Intravenous |
Indications
No indication recorded.